Revenio Group Corporation (REG1V) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Revenio Group Corporation (REG1V) has a cash flow conversion efficiency ratio of -0.029x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.40 Million ≈ $-3.97 Million USD) by net assets (€117.30 Million ≈ $137.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Revenio Group Corporation share price for real-time trading data and today's change.
Revenio Group Corporation - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Revenio Group Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Revenio Group Corporation market cap and net worth for the company's overall valuation and market capitalisation.
Revenio Group Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revenio Group Corporation ranked by their cash flow conversion efficiency. Also see total assets of Revenio Group Corporation for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
|
-0.012x |
|
KNOT Offshore Partners LP
NYSE:KNOP
|
0.054x |
|
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
|
0.101x |
|
Gladstone Land Corporation
NASDAQ:LAND
|
0.014x |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
-0.022x |
|
Guangdong Failong Crystal Technology Co Ltd
SHE:300460
|
0.028x |
|
SMS Electric Co Ltd Zhengzhou
SHE:002857
|
-0.037x |
|
CPH Chemie und Papier Holding
SW:CPHN
|
0.100x |
Annual Cash Flow Conversion Efficiency for Revenio Group Corporation (2001–2025)
The table below shows the annual cash flow conversion efficiency of Revenio Group Corporation from 2001 to 2025. Review Revenio Group Corporation financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €114.70 Million ≈ $134.10 Million |
€30.20 Million ≈ $35.31 Million |
0.263x | +18.79% |
| 2024-12-31 | €107.71 Million ≈ $125.92 Million |
€23.87 Million ≈ $27.91 Million |
0.222x | +103.85% |
| 2023-12-31 | €99.89 Million ≈ $116.79 Million |
€10.86 Million ≈ $12.70 Million |
0.109x | -57.46% |
| 2022-12-31 | €90.92 Million ≈ $106.29 Million |
€23.24 Million ≈ $27.17 Million |
0.256x | -6.79% |
| 2021-12-31 | €78.43 Million ≈ $91.69 Million |
€21.51 Million ≈ $25.15 Million |
0.274x | +25.52% |
| 2020-12-31 | €69.71 Million ≈ $81.50 Million |
€15.23 Million ≈ $17.81 Million |
0.218x | +12.60% |
| 2019-12-31 | €64.36 Million ≈ $75.25 Million |
€12.49 Million ≈ $14.60 Million |
0.194x | -66.34% |
| 2018-12-31 | €18.07 Million ≈ $21.13 Million |
€10.42 Million ≈ $12.18 Million |
0.576x | +17.09% |
| 2017-12-31 | €15.99 Million ≈ $18.69 Million |
€7.87 Million ≈ $9.20 Million |
0.492x | +21.86% |
| 2016-12-31 | €14.97 Million ≈ $17.50 Million |
€6.05 Million ≈ $7.07 Million |
0.404x | -10.85% |
| 2015-12-31 | €15.03 Million ≈ $17.58 Million |
€6.81 Million ≈ $7.96 Million |
0.453x | +97.77% |
| 2014-12-31 | €12.06 Million ≈ $14.10 Million |
€2.76 Million ≈ $3.23 Million |
0.229x | -37.51% |
| 2013-12-31 | €14.96 Million ≈ $17.49 Million |
€5.48 Million ≈ $6.41 Million |
0.367x | +595.09% |
| 2012-12-31 | €14.68 Million ≈ $17.16 Million |
€774.00K ≈ $904.89K |
0.053x | -79.51% |
| 2011-12-31 | €16.43 Million ≈ $19.20 Million |
€4.23 Million ≈ $4.94 Million |
0.257x | +193.03% |
| 2010-12-31 | €14.50 Million ≈ $16.95 Million |
€1.27 Million ≈ $1.49 Million |
0.088x | -29.30% |
| 2009-12-31 | €15.74 Million ≈ $18.40 Million |
€1.96 Million ≈ $2.29 Million |
0.124x | -33.34% |
| 2008-12-31 | €17.59 Million ≈ $20.56 Million |
€3.28 Million ≈ $3.83 Million |
0.186x | +25.09% |
| 2007-12-31 | €22.22 Million ≈ $25.98 Million |
€3.31 Million ≈ $3.87 Million |
0.149x | +163.43% |
| 2006-12-31 | €10.96 Million ≈ $12.81 Million |
€620.00K ≈ $724.85K |
0.057x | -71.65% |
| 2005-12-31 | €5.02 Million ≈ $5.87 Million |
€1.00 Million ≈ $1.17 Million |
0.200x | +332.85% |
| 2004-12-31 | €2.16 Million ≈ $2.52 Million |
€-184.78K ≈ $-216.03K |
-0.086x | +84.26% |
| 2003-12-31 | €1.10 Million ≈ $1.29 Million |
€-600.19K ≈ $-701.68K |
-0.545x | +39.72% |
| 2002-12-31 | €4.32 Million ≈ $5.05 Million |
€-3.90 Million ≈ $-4.56 Million |
-0.903x | -4584.91% |
| 2001-09-30 | €17.72 Million ≈ $20.72 Million |
€357.00K ≈ $417.37K |
0.020x | -- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more